BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18476948)

  • 1. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
    Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
    Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
    Ghaemmaghami F; Karimi-Zarchi M; Modares-Gilani M; Mousavi A; Behtash N
    Asian Pac J Cancer Prev; 2008; 9(4):719-24. PubMed ID: 19256766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
    Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
    Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors.
    Akeson M; Jakobsen AM; Zetterqvist BM; Holmberg E; Brännström M; Horvath G
    Int J Gynecol Cancer; 2009 Jan; 19(1):116-23. PubMed ID: 19258952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
    Hoskins PJ; Le N; Gilks B; Tinker A; Santos J; Wong F; Swenerton KD
    J Clin Oncol; 2012 May; 30(14):1656-62. PubMed ID: 22493415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Pointers for Surgical Staging of Borderline Ovarian Tumors.
    Bendifallah S; Nikpayam M; Ballester M; Uzan C; Fauvet R; Morice P; Darai E
    Ann Surg Oncol; 2016 Feb; 23(2):443-9. PubMed ID: 26442919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
    Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
    Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study.
    Dahm-Kähler P; Palmqvist C; Staf C; Holmberg E; Johannesson L
    Gynecol Oncol; 2016 Aug; 142(2):211-6. PubMed ID: 27238084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
    Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
    du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
    Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
    Boyraz G; Salman MC; Gultekin M; Ozkan NT; Uckan HH; Gungorduk K; Gulseren V; Ayik H; Toptas T; Kuru O; Sozen H; Erturk A; Ozgul N; Meydanlı MM; Sanci M; Turan T; Gungor T; Simsek T; Topuz S; Yuce K
    Arch Gynecol Obstet; 2017 Nov; 296(5):979-987. PubMed ID: 28866783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.
    Okoye E; Euscher ED; Malpica A
    Am J Surg Pathol; 2016 May; 40(5):627-35. PubMed ID: 26900814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer.
    Uzan C; Bontoux LM; Gouy S; Duvillard P; Pautier P; Lhommé C; Morice P
    Int J Gynecol Cancer; 2010 Aug; 20(6):965-70. PubMed ID: 20683403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.